Background: The STOP-BANG questionnaire screens for obstructive sleep apnoea (OSA) in surgical patients. In prior research, the association of STOP-BANG scores with comorbidities and outcomes was inconsistent. The objective of this study was to evaluate the validity of the STOP-BANG score. Methods: We conducted a retrospective cohort study of patients undergoing major elective noncardiac surgery at the University Health Network (Toronto, ON, Canada) between 2011 and 2015. Cross-sectional construct validity was evaluated based on proportions with diagnosed OSA across STOP-BANG strata. Concurrent construct validity was assessed based on the correlation of STOP-BANG with ASA Physical Status (ASA-PS), the Revised Cardiac Risk Index, and the Charlson Comorbidity Index. Predictive validity was assessed based on the adjusted associations of STOP-BANG risk with 30-day mortality (logistic regression), cardiac complications (logistic regression), and length-of-stay (negative binomial regression). Results: Of 26 068 patients in the cohort, 58% were in the low-risk STOP-BANG stratum, 23% in the intermediate-risk stratum, and 19% in the high-risk stratum. The proportion with previously diagnosed OSA was 4% (n¼615) in the low-risk stratum, 12% (n¼740) in the intermediate-risk stratum, and 44% (n¼2142) in the high-risk stratum. The correlations of
Obstructive sleep apnoea (OSA) is growing in prevalence, and has received increasing attention in perioperative medicine owing to challenges in its diagnosis and perioperative management. 1 In prior research, OSA was associated with increased risks of perioperative respiratory complications including respiratory failure, cardiac complications such as atrial fibrillation, and prolonged hospital length-of-stay. 2e6 As most patients with OSA presenting for surgery are undiagnosed, 7 contemporary guidelines often advise anaesthesiologists to screen patients for OSA in the preoperative period. 8, 9 The STOP-BANG questionnaire was developed to screen for OSA and includes eight items (snoring, day time tiredness, observed apnoea, hypertension, BMI >35 kg m À2 , age >50 yr, neck circumference !40 cm, male sex) that generate a summed score. 10 Prior studies have evaluated several different aspects of its validity, 11 both when questionnaire responses were expressed as the STOP-BANG scores themselves or risk strata categorised using recommended definitions (Table 1) . 12, 13 In general, prior findings with respect to the associations of STOP-BANG scores with comorbidities and outcomes have been inconsistent. For example the magnitude of associations of STOP-BANG scores with age, ASA Physical Status (ASA-PS) classification, and some comorbidities (e.g. ischaemic heart disease) have been variable. 14e16 It is thus unclear whether STOP-BANG is a unique risk stratification index or whether it is a marker of other recognised indices of perioperative risk. Similarly, the associations between STOP-BANG scores with postoperative outcomes are inconsistent. 10, 12, 17, 18 While a recent meta-analysis found that high STOP-BANG scores were associated with a nearly four-fold increased odds of cardiorespiratory complications requiring ICU admission and increased hospital length-of-stay, 17 there was significant heterogeneity across samples and outcome definitions. In addition, another large prospective cohort study found no adjusted association between STOP-BANG with mortality up to 1 yr after surgery. 18 Given these inconsistent associations between STOP-BANG scores with comorbidities and outcomes, we undertook a retrospective cohort study to evaluate the validity of STOP-BANG scores assigned before operation in a large surgical cohort, including: cross-sectional construct validity based on proportions of patients with known OSA among STOP-BANG strata; concurrent construct validity using correlations of STOP-BANG scores with the ASA-PS classification, Revised Cardiac Risk Index, and Charlson Comorbidity Index; and predictive criterion validity based on adjusted associations of STOP-BANG risk strata with 30-day mortality, major cardiac complications, and hospital length-of-stay. 
Variables
The primary exposure, STOP-BANG risk stratum, was assigned in the preoperative evaluation clinic as low-risk (scores from ). 10 As neck circumference was not captured systematically at one study site, the primary analyses were performed without including neck circumference data in the calculation of STOP-BANG scores.
In addition, we captured information on patients' age, sex, surgical procedure, hospital length-of-stay, in-hospital 30-day mortality, and postoperative cardiac complications (defined as the composite of heart failure, cardiac arrest, and myocardial injury) from the EDW. Myocardial injury was defined as a postoperative troponin I concentration exceeding 0.30 mg L
À1
(Architect Immunoassay System, Abbott Diagnostics, Lake Forest, IL, USA). Comorbidities were ascertained from the preoperative assessment records, including smoking status, hypertension, coronary artery disease, heart failure, diabetes mellitus, cerebrovascular disease, cancer, asthma, OSA, and chronic obstructive pulmonary disease (COPD). Using the preoperative creatinine concentration from the clinic, chronic kidney disease was defined as an estimated glomerular filtration rate (eGFR) less than 30 ml min À1 based on the Cockcroft-Gault equation. The ASA-PS class was defined as the classification assigned by the attending anaesthesiologist in the preoperative assessment clinic. The Revised Cardiac Risk Index was defined based on data from the preoperative clinic (for comorbidities) and the EDW (for surgical procedure and preoperative creatinine concentration). The presence of individual comorbidities comprising the Charlson Comorbidity Index was determined based on preadmission ICD-10 diagnostic codes within the EDW.
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Statistical analysis
Statistical analyses were completed using SAS version 9.4 (Cary, NC, USA). A two-tailed P-value <0.05 was used to define statistical significance. Summary statistics were generated for the study sample; categorical variables were described using counts and proportions, while continuous variables were described using means, medians, standard deviations, and inter-quartile ranges. The distribution of four continuous variables, age, BMI, surgical duration, and length-of-stay, was assessed using histogram plots and the Kolmogorov-Smirnov test of normality. Next, univariate statistics were performed to compare patient characteristics (age, sex, BMI, comorbidities), surgical procedure, surgical duration, and comorbidity indices across STOP-BANG risk strata. The median values of 
Assessment of cross-sectional construct validity
Cross-sectional construct validity refers to whether the STOP-BANG questionnaire measures the construct it was intended to measure. 11 It was assessed by measuring the proportion of patients with a known preoperative diagnosis of OSA within each STOP-BANG risk stratum. 
Assessment of concurrent construct validity
Assessment of predictive criterion validity
Predictive validity describes the extent to which the STOP-BANG questionnaire can predict future related clinical events. 11 It was assessed by measuring the extent to which the STOP-BANG questionnaire predicted 30-day mortality, postoperative cardiac complications, and hospital length-of-stay. 11 We first conducted univariate analyses of STOP-BANG risk strata with these outcomes. These unadjusted analyses of STOP-BANG with outcome were conducted using logistic regression models for 30-day mortality and postoperative cardiac complications, and a negative binomial regression model for hospital length-of-stay. The only exposure variable in these models was the STOP-BANG risk stratum. Finally, adjusted associations of STOP-BANG with postoperative outcomes were examined using multivariable regression analyses. Separate models were generated for each outcome; the following predictors were selected a priori for inclusion into the multivariable models: the key predictord-STOP-BANG risk stratum, age, sex, patient comorbidities, and surgical procedure. The included comorbidities were age, smoking status, COPD, coronary artery disease, diabetes mellitus, heart failure, cerebrovascular disease, chronic kidney disease, and cancer. The adjusted associations of STOP-BANG with the categorical outcomes (30-day mortality and postoperative cardiac complications) were examined using multivariable logistic regression models. The adjusted association of STOP-BANG with hospital length-of-stay was examined using a multivariable negative binomial regression model. Underlying model assumptions were verified.
Sensitivity analyses
To examine the potential influence of missing neck circumference data, a sensitivity analysis was conducted restricted to sites with complete data. Specifically, we calculated the proportion of patients whose STOP-BANG risk strata allocation was re-classified after accounting for neck circumference. Multivariable regression analyses of predictive criterion validity were also repeated in this subset to verify the results of the primary analyses.
Results
The cohort comprised 26 068 patients, including 15 126 (58%) at low risk, 6056 (23%) at intermediate risk, and 4886 (19%) at high risk based on STOP-BANG. Characteristics of the cohort are presented in Table 2 . Overall, about 3% (n¼1331) of the study cohort underwent bariatric surgery. The STOP-BANG risk strata differed significantly with respect to age, sex, BMI, comorbidities, surgical procedure, surgery duration, and anaesthesia type ( Table 2 ). About 1.6% (n¼423) of the cohort died within 30 days after surgery, while 16% (n¼4144) had major cardiac complications. The median length-of-stay was 3 days (inter-quartile range 2e5).
Cross-sectional construct validity
The proportion of patients with known OSA in each STOP-BANG risk stratum is presented in Supplementary Figure S1 . Four percent (n¼615) of the low STOP-BANG risk stratum had a known OSA diagnosis, compared with 12% (n¼740) of the intermediate-risk stratum and 44% (n¼2142) of the high-risk stratum.
Concurrent construct validity
The correlation between STOP-BANG and the ASA-PS, RCRI, and CCI were each examined using the Spearman's r rank correlation coefficient; statistically significant (P<0.001) albeit weak correlations were observed between STOP-BANG with the ASA-PS (r¼0.28) and Revised Cardiac Risk Index (r¼0.24), and a very weak statistically significant (P<0.001) correlation was observed between STOP-BANG and the Charlson Comorbidity Index (r¼0.10).
Predictive criterion validity
The unadjusted associations of STOP-BANG with postoperative outcomes are presented in Table 3 . In unadjusted analyses, STOP-BANG risk strata were generally associated Tables 4 and 5 and  Supplementary Table S1 . After adjustment for patient and surgical factors, STOP-BANG risk strata are not associated with 30-day mortality, major cardiac complications, and hospital length-of-stay (Tables 4 and 5 and Supplementary Table S1 ). After multivariable adjustment, factors significantly associated with 30-day mortality included: age, COPD, diabetes mellitus, heart failure, chronic kidney disease, metastatic cancer, and surgical procedure ( Table 4 ). The factors independently associated with major cardiac complications are: age, sex, COPD, coronary artery disease, diabetes mellitus, heart failure, chronic kidney disease, cancer, and surgical procedure (Table 5) . Finally, age, smoking status, comorbid conditions (COPD, coronary artery disease, diabetes mellitus, heart failure, chronic kidney disease, and cancer) and surgical procedure were significantly associated with length-of-stay (Supplementary Table S1 ).
In a sensitivity analysis at sites with complete neck circumference data (n¼14,071), 5% (n¼684) of patients were reclassified to a higher risk stratum when neck circumference was included (Supplementary Fig. S2 ). In assessing the predictive criterion validity of the STOP-BANG risk strata in this subset, the findings were unchanged: statistically significant associations were observed between STOP-BANG risk strata with 30-day mortality, major cardiac complications, and length-of-stay in unadjusted analyses. These associations diminished when adjusting for patient and surgical factors.
Discussion
In this retrospective cohort study of patients undergoing major elective noncardiac surgery, the STOP-BANG questionnaire demonstrated cross-sectional construct validity in that increasing proportions of patients had a recognised OSA diagnosis in elevated STOP-BANG risk strata. In terms of concurrent construct validity, STOP-BANG scores had only weak correlation to the ASA-PS, Revised Cardiac Risk Index, and Charlson Comorbidity Index, suggesting that STOP-BANG measures a differentdperhaps respiratorydconstruct compared with the other indices, which measure general patient health and cardiac risk. Finally, in terms of predictive criterion validity, the STOP-BANG score was associated with 30-day mortality, cardiac complications, and length-of-stay in unadjusted analyses; however, these associations did not follow a dose-response relationship and the high-risk stratum was not associated with 30-day mortality. After adjustment for patient comorbidities and surgical factors, these associations diminished, suggesting that the association of STOP-BANG with non-respiratory outcomes in this cohort is largely explained by known risk factors.
Although the lack of polysomnography data on all patients in our cohort precluded calculating the sensitivity and specificity, our study exhibited cross-sectional construct validity of STOP-BANG in that increasing proportions of patients had a known OSA diagnosis in the intermediate and high STOP-BANG risk strata using new STOP-BANG risk strata. In fact, 42% of the present cohort were at intermediate or high STOP-BANG risk, with 11% and 44% of intermediate-and high-risk patients, respectively, having a known OSA diagnosis. The low proportion of patients diagnosed with OSA, 7 particularly in the intermediate-risk stratum, highlights the possibility of undiagnosed OSA in our cohort. In addition to evaluating the cross-sectional construct validity of the STOP-BANG questionnaire, we assessed its concurrent construct validity based on correlations with the ASA-PS, Revised Cardiac Risk Index, and Charlson Comorbidity Index. These analyses revealed statistically significant positive correlations of STOP-BANG with each of these tools; however, the magnitude of these associations was weak (with ASA-PS and Revised Cardiac Risk Index) and very weak (with Charlson Comorbidity Index). The positive correlations observed imply that increasing STOP-BANG scores are correlated with worse preoperative health status and increased risk of major adverse cardiac events, respectively, and consistent with some previous research. 14e16 The relatively poor correlation may be explained, in part, by the differing purposes for which each scale was derived: STOP-BANG was created as a screening tool for OSA 10 ; ASA-PS was created as a measure of preoperative health status, Revised Cardiac Risk Index as a risk index for perioperative major adverse cardiac events, 23 and
Charlson Comorbidity Index as a measure of the burden of comorbidity among hospitalised patients. 21 In contrast, STOP-BANG, given its association with OSA, may be a measure of perioperative respiratory risk. Finally, the predictive criterion validity of the STOP-BANG revealed significant associations with 30-day mortality, postoperative cardiac complications, and hospital length-of-stay in unadjusted analyses. These associations had two caveats: first, the high STOP-BANG risk stratum was not associated with 30-day mortality, and second, the expected doseresponse relationships of STOP-BANG with outcomes, where the high-risk stratum had increased odds of the outcome compared with the intermediate-risk stratum, were not observed. These findings in the high-risk stratum may be the result of perioperative management of known OSA, where patients who more frequently harboured an OSA diagnosis are more likely to have been treated with CPAP. There is some evidence of reduced risk of complications for treated rather than untreated OSA, 24, 25 which may account for the results observed herein.
The adjusted association of STOP-BANG with these outcomes was not statistically significant, suggesting that the associations found in unadjusted analyses were accounted for by known patient and surgical risk factors. The absence of an adjusted association with mortality is not surprising given the existing literature. The association of OSA, which the STOP-BANG questionnaire screens for, with postoperative mortality, has largely not been observed. For instance, in the large Vascular Events in Noncardiac Surgery (VISION) study, OSA was not an independent predictor of 30-day mortality. 26 Studies utilising health administrative data have revealed associations of OSA with postoperative mortality among patients undergoing revision arthroplasty, but not general surgery or other orthopaedic procedures 4, 5 ; however, these studies are subject to important limitations in diagnostic accuracy and high likelihood of misclassification biases. 27 We found no adjusted association of STOP-BANG risk strata with mortality, in keeping with a large prospective cohort of unselected patients undergoing inpatient surgery, where neither screened (using STOP-BANG) nor diagnosed OSA was significantly associated with mortality up to 1 yr after surgery. 18 Conversely, a previous review of case reports of surgical patients with OSA found that components of the STOP-BANG score, such as morbid obesity and male sex, were risk factors for death or critical respiratory events. 28 However, these previous findings are limited by the publication bias inherent to case reports, with only 60 individual patients being included. Furthermore, this review focused on risk factors specifically within the subgroup of individuals with OSA; conversely, our present study focused on risk factors within the broader group of surgical patients undergoing major elective noncardiac surgery. Our finding of no adjusted association of STOP-BANG risk strata with major cardiac complications and hospital lengthof-stay contrasts some previous research. For instance, a recent meta-regression exhibited a nearly four-fold increase in cardiopulmonary complications potentially requiring admission to an ICU; the same study also exhibited an increased risk of longer hospital length-of-stay among intermediate or high STOP-BANG risk strata. 17 It must be noted that significant heterogeneity existed among the studies included in this analysis; it may be plausible that the association of STOP-BANG with respiratory complications was driving the pooled effect observed. More robust associations of STOP-BANG with respiratory complications have also since been exhibited, 29 although a recent prospective study found no predictive ability for postoperative hypoxaemia. 30 Our study, including only cardiac complications, did not find a significant adjusted association in these complications between the STOP-BANG risk strata. Finally, our contrasting finding of no significant association of STOP-BANG with hospital length-of-stay 17 may be explained by the fact that our dataset contained detailed surgical procedural data, which were included as predictors in our model; nearly all surgical types were significantly associated with hospital length-of-stay. Our study has certain limitations. First, it was a retrospective cohort study comprising one quaternary care hospital network in a single city. A similar study replicated at other centres with differing case-mixes is necessary to generalise our findings to other practice settings. Importantly, relatively few study participants underwent bariatric surgery. Thus, further work is necessary to determine whether our findings extend to this subpopulation at high risk of OSA. Furthermore, our study was limited in that respiratory complications were not captured by our linked databases. We are thus unable to examine the predictive criterion validity of STOP-BANG when predicting respiratory complications. Next, as STOP-BANG questionnaires were collected as part of clinical practice, there is a possibility of high STOP-BANG risk stratum patients receiving heightened perioperative levels of care. While unadjusted analyses revealed significant associations between STOP-BANG with outcomes, it is possible that heightened levels of care among intermediate-risk and high-risk strata patients diminished the magnitude of association between STOP-BANG and outcomes. Finally, neck circumference data was not collected systematically at one study site. However, sensitivity analyses of sites with complete data revealed no differences in results, with similar associations of STOP-BANG with outcomes in unadjusted analyses, which diminished with adjustment for patient and surgical factors. To address these limitations, confirm our present findings, and further inform the clinical utility of the STOP-BANG questionnaire, future prospective studies should systematically measure neck circumference, and systematically ascertain the presence of respiratory complications, cardiac complications, and mortality.
In conclusion, the STOP-BANG questionnaire exhibited cross-sectional construct validity, which supports its ongoing use as a preoperative screening tool for OSA. However, its limited concurrent construct validity based on weak associations with other health indices suggests that it measures a different construct and may not be used in their place. Finally, the low criterion validity precludes its use as a predictive index, as associations between STOP-BANG and non-respiratory postoperative outcomes are likely better explained by known patient and surgical risk factors. 
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